Prokidney (PROK) Share-based Compensation (2021 - 2026)

Prokidney (PROK) has 6 years of Share-based Compensation data on file, last reported at $4.9 million in Q1 2026.

• Share-based Compensation for Q1 2026 came in at $4.9 million, down 11.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.1 million (down 32.36% YoY), and the FY2025 annual result was $22.4 million, down 23.88% from the prior year.
• Share-based Compensation improved to $4.9 million in Q1 2026 per PROK's latest filing, from $2.7 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $52.7 million in Q1 2022 and troughed at $1.5 million in Q4 2023.
• A 5-year average of $9.7 million and a median of $6.9 million in 2024 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation surged 5008.57% in 2022, then slumped 83.47% in 2023.
• A 5-year view of Share-based Compensation shows it stood at $8.9 million in 2022, then tumbled by 83.47% to $1.5 million in 2023, then soared by 631.6% to $10.8 million in 2024, then sank by 74.81% to $2.7 million in 2025, then soared by 81.53% to $4.9 million in 2026.
• Business Quant data shows PROK's Share-based Compensation at $4.9 million in Q1 2026, $2.7 million in Q4 2025, and $5.9 million in Q3 2025.